GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,450 | +1.7% | 40 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,426 | +14160.0% | 40 | -85.9% | 0.00% | -80.0% |
| Q1 2023 | $10 | +11.1% | 283 | +16.5% | 0.01% | +25.0% |
| Q4 2022 | $9 | -99.9% | 243 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $7,000 | -53.3% | 243 | -69.8% | 0.01% | 0.0% |
| Q2 2022 | $15,000 | -16.7% | 804 | 0.0% | 0.01% | -14.3% |
| Q1 2022 | $18,000 | -10.0% | 804 | 0.0% | 0.01% | -22.2% |
| Q4 2021 | $20,000 | -16.7% | 804 | 0.0% | 0.01% | -18.2% |
| Q3 2021 | $24,000 | +100.0% | 804 | +164.5% | 0.01% | +83.3% |
| Q2 2021 | $12,000 | +9.1% | 304 | 0.0% | 0.01% | +20.0% |
| Q1 2021 | $11,000 | 0.0% | 304 | +1.3% | 0.01% | 0.0% |
| Q4 2020 | $11,000 | -69.4% | 300 | -68.4% | 0.01% | -75.0% |
| Q3 2020 | $36,000 | +33.3% | 950 | +46.2% | 0.02% | +17.6% |
| Q2 2020 | $27,000 | -12.9% | 650 | 0.0% | 0.02% | -15.0% |
| Q4 2019 | $31,000 | – | 650 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |